Hydroxocobalamin Injection shortage
Current 2 presentations · 2 manufacturers · first FDA posting Nov 4, 2024 · last update Oct 15, 2026
Manufacturers: BTG International Inc., Teva Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Other
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Cyanokit, Injection, 5 g/250mL (NDC 50633-310-11) | BTG International Inc. | Current Limited Availability |
Other | Cyanokit is available to order. To address the drug shortage, BTG International Inc (a SERB Pharmaceuticals company) coordinated with the U.S. Food and Drug Administration (FDA) to make the following impacted batches available to U.S. patients during this period of shortage. | Posted Nov 4, 2024 Updated Oct 1, 2026 |
| Hydroxocobalamin, Injection, 1000 MCG/ML, 30 ML Multi-Dose Vial (NDC 0591-2888-30) | Teva Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Estimated recovery: mid-November 2026 | Posted Nov 4, 2024 Updated Oct 15, 2026 |